COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection | SpringerLink
Role of angiotensin-converting enzyme 2 in neurodegenerative diseases during the COVID-19 pandemic | Aging
Elevated serum angiotensin converting enzyme levels as a reflection of bone marrow renin–angiotensin system activation in multiple myeloma - Murat Albayrak, Harika Celebi, Aynur Albayrak, Abdurrahim Sayilir, Yusuf Yesil, Ozlem Sahin Balcik,
Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19 | Critical Care | Full Text
Lower Serum Angiotensin-Converting Enzyme Level in Relation to Hyperinflammation and Impaired Antiviral Immune Response Contributes to Progression of COVID-19 Infection | Infectious Diseases and Therapy
Angiotensin-converting enzyme 2 and angiotensin 1–7: novel therapeutic targets | Nature Reviews Cardiology
Serum angiotensin‐converting enzyme levels indicating early sarcoidosis diagnosis and immunosuppressive therapy efficacy - Kawai - 2023 - ESC Heart Failure - Wiley Online Library
Pathways: ACE Inhibitor Pathway | www.antibodies-online.com
Angiotensin-converting enzyme in innate and adaptive immunity | Nature Reviews Nephrology
Plasma ACE2 and risk of death or cardiometabolic diseases: a case-cohort analysis - The Lancet
Dysregulation of ACE (Angiotensin-Converting Enzyme)-2 and Renin-Angiotensin Peptides in SARS-CoV-2 Mediated Mortality and End-Organ Injuries | Hypertension
Decrease in Angiotensin-Converting Enzyme activity but not concentration in plasma/lungs in COVID-19 patients offers clues for diagnosis/treatment: Molecular Therapy - Methods & Clinical Development
High serum angiotensin-converting enzyme 2 activity as a biomarker of frailty in nursing home residents - ScienceDirect
Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19 | Critical Care | Full Text
Angiotensin converting enzyme: A review on expression profile and its association with human disorders with special focus on SARS-CoV-2 infection - ScienceDirect
Human ACE2 ELISA Assay | Angiotensin converting Enzyme 2
Angiotensin-converting enzyme 2 receptors, chronic liver diseases, common medications, and clinical outcomes in coronavirus disease 2019 patients
Ang II (Angiotensin II) Conversion to Angiotensin-(1-7) in the Circulation Is POP (Prolyloligopeptidase)-Dependent and ACE2 (Angiotensin-Converting Enzyme 2)-Independent | Hypertension
The Angiotensin-converting Enzyme Insertion/Deletion Polymorphism as a Common Risk Factor for Major Pregnancy Complications | In Vivo
Genotype-corrected reference values for serum angiotensin-converting enzyme | European Respiratory Society
Human recombinant soluble ACE2 in severe COVID-19 - The Lancet Respiratory Medicine
Frontiers | Angiotensin Converting Enzyme 2 (ACE2) in Pregnancy: Preeclampsia and Small for Gestational Age
Frontiers | Regulation of Angiotensin-Converting Enzyme 2: A Potential Target to Prevent COVID-19?
Frontiers | ACE2 Shedding and the Role in COVID-19
Genotype-corrected reference values for serum angiotensin-converting enzyme | European Respiratory Society
Human recombinant soluble ACE2 (hrsACE2) shows promise for treating severe COVID19 | Signal Transduction and Targeted Therapy
